Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Timothy M. Millar is active.

Publication


Featured researches published by Timothy M. Millar.


FEBS Letters | 1998

Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions

Timothy M. Millar; Cliff R. Stevens; Nigel Benjamin; Robert Eisenthal; Roger Harrison; David R. Blake

Xanthine oxidoreductase (XOR) catalyses the reduction of the therapeutic organic nitrate, nitroglycerin (glyceryl trinitrate, GTN), as well as inorganic nitrate and nitrite, to nitric oxide (NO) under hypoxic conditions in the presence of NADH. Generation of nitric oxide is not detectable under normoxic conditions and is inhibited by the molybdenum site‐specific inhibitors, oxypurinol and (−)BOF 4272. These enzymic reactions provide a mechanism for generation of NO under hypoxic conditions where nitric oxide synthase does not function, suggesting a vasodilatory role in ischaemia.


The Lancet | 2000

Antibacterial properties of xanthine oxidase in human milk

Clifford Robert Stevens; Timothy M. Millar; J.G. Clinch; Janos M. Kanczler; Tulin Bodamyali; David R. Blake

Formula-fed babies contract gastroenteritis more than breast-fed babies, which is of concern to mothers who cannot breastfeed or, as with HIV-infected mothers, are discouraged from breastfeeding. The ability of endogenous breastmilk xanthine oxidase to generate the antimicrobial radical nitric oxide has been measured and its influence on the growth of Escherichia coli and Salmonella enteritides examined. Breastmilk, but not formula feed, generated nitric oxide. Xanthine oxidase activity substantially inhibited the growth of both bacteria. An important natural antibiotic system is missing in formula feeds; the addition of xanthine oxidase may improve formula for use when breastfeeding is not a safe option.


Small | 2012

Interactions of human endothelial cells with gold nanoparticles of different morphologies

Dorota Bartczak; Otto L. Muskens; Simone Nitti; Tilman Sanchez-Elsner; Timothy M. Millar; Antonios G. Kanaras

The interactions between noncancerous, primary endothelial cells and gold nanoparticles with different morphologies but the same ligand capping are investigated. The endothelial cells are incubated with gold nanospheres, nanorods, hollow gold spheres, and core/shell silica/gold nanocrystals, which are coated with monocarboxy (1-mercaptoundec-11-yl) hexaethylene glycol (OEG). Cell viability studies show that all types of gold particles are noncytotoxic. The number of particles taken up by the cells is estimated using inductively coupled plasma (ICP), and are found to differ depending on particle morphology. The above results are discussed with respect to heating efficiency. Using experimental data reported earlier and theoretical model calculations which take into account the physical properties and distribution of particles in the cellular microenvironment, it is found that collective heating effects of several cells loaded with nanoparticles must be included to explain the observed viability of the endothelial cells.


Small | 2011

Receptor-mediated interactions between colloidal gold nanoparticles and human umbilical vein endothelial cells.

Dorota Bartczak; Tilman Sanchez-Elsner; Fethi Louafi; Timothy M. Millar; Antonios G. Kanaras

A new strategy to manipulate cell operations is demonstrated, based on membrane-receptor-specific interactions between colloidal peptide-capped gold nanoparticles and human umbilical vein endothelial cells. It is shown that colloidal gold nanoparticles of similar charge and size but capped with different peptide sequences can deliberately trigger specific cell functions related to the important biological process of blood vessel growth known as angiogenesis. Specific binding of the peptide-capped particles to two endothelial-expressed receptors (VEGFR-1, NRP-1), which control angiogenesis, is achieved. The cellular fate of the functional nanoparticles is imaged and the influence of the different peptide-coated nanoparticles on the gene expression profile of hypoxia-related and angiogenic genes is monitored. The findings open up new avenues towards the deliberate biological control of cellular functions using strategically designed nanoparticles.


Nano Letters | 2011

Laser-induced damage and recovery of plasmonically targeted human endothelial cells

Dorota Bartczak; Otto L. Muskens; Timothy M. Millar; Tilman Sanchez-Elsner; Antonios G. Kanaras

Laser-induced techniques that employ the surface plasmon resonances of nanoparticles have recently been introduced as an effective therapeutic tool for destroying tumor cells. Here, we adopt a low-intensity laser-induced technique to manipulate the damage and repair of a vital category of noncancerous cells, human endothelial cells. Endothelial cells construct the interior of blood vessels and play a pivotal role in angiogenesis. The degree of damage and repair of the cells is shown to be influenced by laser illumination in the presence of gold nanoparticles of different morphologies, which either target the cellular membrane or are endocytosed. A pronounced influence of the plasmonic nanoparticle laser treatment on the expression of critical angiogenic genes is shown. Our results show that plasmon-mediated mild laser treatment, combined with specific targeting of cellular membranes, enables new routes for controlling cell permeability and gene regulation in endothelial cells.


ACS Nano | 2013

Manipulation of in Vitro Angiogenesis Using Peptide-Coated Gold Nanoparticles

Dorota Bartczak; Otto L. Muskens; Tilman Sanchez-Elsner; Antonios G. Kanaras; Timothy M. Millar

We demonstrate the deliberate activation or inhibition of invitro angiogenesis using functional peptide coated gold nanoparticles. The peptides, anchored to oligo-ethylene glycol capped gold nanospheres, were designed to selectively interact with cell receptors responsible for activation or inhibition of angiogenesis. The functional particles are shown to influence significantly the extent and morphology of vascular structures, without causing toxicity. Mechanistic studies show that the nanoparticles have the ability to alter the balance between naturally secreted pro- and anti-angiogenic factors, under various biological conditions. Nanoparticle-induced control over angiogenesis opens up new directions in targeted drug delivery and therapy.


FEBS Letters | 2004

Peroxynitrite formation from the simultaneous reduction of nitrite and oxygen by xanthine oxidase

Timothy M. Millar

One electron reductions of oxygen and nitrite by xanthine oxidase form peroxynitrite. The nitrite and oxygen reducing activities of xanthine oxidase are regulated by oxygen with K oxygen 26 and 100 μM and K nitrite 1.0 and 1.1 mM with xanthine and NADH as donor substrates. Optimal peroxynitrite formation occurs at 70 μM oxygen with purine substrates. Kinetic parameters: V max∼50 nmol/min/mg and K m of 22, 36 and 70 μM for hypoxanthine, pterin and nitrite respectively. Peroxynitrite generation is inhibited by allopurinol, superoxide dismutase and diphenylene iodonium. A role for this enzyme activity can be found in the antibacterial activity of milk and circulating xanthine oxidase activity.


Redox Report | 2002

Xanthine oxidase is a peroxynitrite synthase: newlyidentified roles for a very old enzyme

Timothy M. Millar; Janos M. Kanczler; Tulin Bodamyali; David R. Blake; Cliff R. Stevens

Xanthine oxidase (XO) was first identified in 1902 by the German scientist Schardinger in bovine milk by following the hydroxylation of hypoxanthine to xanthine. 1 Following this first discovery, the history of xanthine oxidase has followed the usual routes of investigation such as they were at the start of the 20th century. The electron donors and acceptors were identified and the constituents of the active sites were deduced. It turns out to be a classic, multicentred, redox enzyme. For many years the function of the enzyme in milk was questioned and various theories were proffered. These ideas ranged from being a carrier of iron and molybdenum to the infant, to purely an additional dietary protein, a notion still prevalent in the medical profession today. XO was thought not to have an enzymic role in milk. However, further thought on the matter brings to light the high, almost neutral pH of the neonatal gut in the first few weeks post partum. The acid pH, which develops later in life, acts as the primary defence to infective organisms via ingestion. In this time before the acid develops, other systems must be in place. The role of a radical generating enzyme may, therefore, be in the reduction of infective bacteria by the generation of superoxide and hydrogen peroxide. Unfortunately, the potency of these reactive oxygen species is dependent on a number of factors including detoxification enzymes in bacteria, particularly superoxide dismutases and catalase, and the availability of oxygen in the environment. In 1996, we began to study the nitrate reductase activity of XO, a largely ignored phenomenon, which culminated in the first description of nitrate and nitrite reductase activities with the formation of nitric oxide (NO) as the end product. 2‐4 In the light of these findings and our further studies, we have developed and tested the theory that XO-generated reactive molecules have antibacterial activities in the neonatal gut (see Fig. 1). It raises the possibility that, in areas where breast-feeding is not possible due to HIV infection in the mother, an alternative formula can be employed to reduce life-threatening diarrhoeal disease. This system acts as a low-cost, naturally occurring antibiotic for the reduction of infective bacteria. But first some background and comparative biochemistry.


PLOS ONE | 2015

Temporal Monitoring of Differentiated Human Airway Epithelial Cells Using Microfluidics

Cornelia Blume; Riccardo Reale; Marie Held; Timothy M. Millar; Jane E. Collins; Donna E. Davies; Hywel Morgan; Emily J. Swindle

The airway epithelium is exposed to a variety of harmful agents during breathing and appropriate cellular responses are essential to maintain tissue homeostasis. Recent evidence has highlighted the contribution of epithelial barrier dysfunction in the development of many chronic respiratory diseases. Despite intense research efforts, the responses of the airway barrier to environmental agents are not fully understood, mainly due to lack of suitable in vitro models that recapitulate the complex in vivo situation accurately. Using an interdisciplinary approach, we describe a novel dynamic 3D in vitro model of the airway epithelium, incorporating fully differentiated primary human airway epithelial cells at the air-liquid interface and a basolateral microfluidic supply of nutrients simulating the interstitial flow observed in vivo. Through combination of the microfluidic culture system with an automated fraction collector the kinetics of cellular responses by the airway epithelium to environmental agents can be analysed at the early phases for the first time and with much higher sensitivity compared to common static in vitro models. Following exposure of primary differentiated epithelial cells to pollen we show that CXCL8/IL–8 release is detectable within the first 2h and peaks at 4–6h under microfluidic conditions, a response which was not observed in conventional static culture conditions. Such a microfluidic culture model is likely to have utility for high resolution temporal profiling of toxicological and pharmacological responses of the airway epithelial barrier, as well as for studies of disease mechanisms.


ACS Sensors | 2017

Graphene Oxide-Upconversion Nanoparticle Based Optical Sensors for Targeted Detection of mRNA Biomarkers Present in Alzheimer’s Disease and Prostate Cancer

Patrick Vilela; Afaf H. El-Sagheer; Timothy M. Millar; Tom Brown; Otto L. Muskens; Antonios G. Kanaras

The development of new sensors for the accurate detection of biomarkers in biological fluids is of utmost importance for the early diagnosis of diseases. Next to advanced laboratory techniques, there is a need for relatively simple methods which can significantly broaden the availability of diagnostic capability. Here, we demonstrate the successful application of a sensor platform based on graphene oxide and upconversion nanoparticles (NPs) for the specific detection of mRNA-related oligonucleotide markers in complex biological fluids. The combination of near-infrared light upconversion with low-background photon counting readout enables reliable detection of low quantities of small oligonucleotide sequences in the femtomolar range. We demonstrate the successful detection of analytes relevant to mRNAs present in Alzheimers disease as well as prostate cancer in human blood serum. The high performance and relative simplicity of the upconversion NP-graphene sensor platform enables new opportunities in early diagnosis based on specific detection of oligonucleotide sequences in complex environments.

Collaboration


Dive into the Timothy M. Millar's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

David R. Blake

Royal National Hospital for Rheumatic Diseases

View shared research outputs
Top Co-Authors

Avatar

Dorota Bartczak

University of Southampton

View shared research outputs
Top Co-Authors

Avatar

Otto L. Muskens

University of Southampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge